Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Sci Rep ; 11(1): 12514, 2021 06 15.
Article in English | MEDLINE | ID: mdl-34131160

ABSTRACT

Multidrug resistance bacteria constitue an increasing global health problem and the development of novel therapeutic strategies to face this challenge is urgent. Antimicrobial peptides have been proven as potent agents against pathogenic bacteria shown by promising in vitro results. The aim of this study was to characterize the antimicrobial effects of PLNC8 αß on cell signaling pathways and inflammatory responses of human keratinocytes infected with S. aureus. PLNC8 αß did not affect the viability of human keratinocytes but upregulated several cytokines (IL-1ß, IL-6, CXCL8), MMPs (MMP1, MMP2, MMP9, MMP10) and growth factors (VEGF and PDGF-AA), which are essential in cell regeneration. S. aureus induced the expression of several inflammatory mediators at the gene and protein level and PLNC8 αß was able to significantly suppress these effects. Intracellular signaling events involved primarily c-Jun via JNK, c-Fos and NFκB, suggesting their essential role in the initiation of inflammatory responses in human keratinocytes. PLNC8 αß was shown to modulate early keratinocyte responses, without affecting their viability. The peptides have high selectivity towards S. aureus and were efficient at eliminating the bacteria and counteracting their inflammatory and cytotoxic effects, alone and in combination with low concentrations of gentamicin. We propose that PLNC8 αß may be developed to combat infections caused by Staphylococcus spp.


Subject(s)
Anti-Bacterial Agents/pharmacology , Keratinocytes/drug effects , Staphylococcal Infections/drug therapy , Staphylococcus aureus/drug effects , Cell Line , Cell Survival/drug effects , Cytokines/genetics , Gene Expression Regulation/drug effects , Humans , Intercellular Signaling Peptides and Proteins/genetics , Interleukin-1beta/genetics , Staphylococcal Infections/microbiology , Staphylococcal Infections/pathology , Staphylococcus aureus/pathogenicity , Transcriptional Activation/drug effects
3.
Sci Rep ; 10(1): 3580, 2020 02 27.
Article in English | MEDLINE | ID: mdl-32107445

ABSTRACT

The use of conventional antibiotics has substantial clinical efficacy, however these vital antimicrobial agents are becoming less effective due to the dramatic increase in antibiotic-resistant bacteria. Novel approaches to combat bacterial infections are urgently needed and bacteriocins represent a promising alternative. In this study, the activities of the two-peptide bacteriocin PLNC8 αß were investigated against different Staphylococcus spp. The peptide sequences of PLNC8 α and ß were modified, either through truncation or replacement of all L-amino acids with D-amino acids. Both L- and D-PLNC8 αß caused rapid disruption of lipid membrane integrity and were effective against both susceptible and antibiotic resistant strains. The D-enantiomer was stable against proteolytic degradation by trypsin compared to the L-enantiomer. Of the truncated peptides, ß1-22, ß7-34 and ß1-20 retained an inhibitory activity. The peptides diffused rapidly (2 min) through the bacterial cell wall and permeabilized the cell membrane, causing swelling with a disorganized peptidoglycan layer. Interestingly, sub-MIC concentrations of PLNC8 αß substantially enhanced the effects of different antibiotics in an additive or synergistic manner. This study shows that PLNC8 αß is active against Staphylococcus spp. and may be developed as adjuvant in combination therapy to potentiate the effects of antibiotics and reduce their overall use.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacteriocins/pharmacology , Staphylococcus/drug effects , Anti-Bacterial Agents/chemistry , Bacteriocins/chemistry , Bacteriocins/genetics , Drug Resistance, Bacterial , Microbial Sensitivity Tests , Staphylococcus/growth & development
4.
Future Microbiol ; 14: 195-205, 2019 02.
Article in English | MEDLINE | ID: mdl-30648887

ABSTRACT

AIM: Bacteriocins are considered as promising alternatives to antibiotics against infections. In this study, the plantaricins (Pln) A, E, F, J and K were investigated for their antimicrobial activity against Staphylococcus epidermidis. MATERIALS & METHODS: The effects on membrane integrity were studied using liposomes and viable bacteria, respectively. RESULTS: We show that PlnEF and PlnJK caused rapid and significant lysis of S. epidermidis, and induced lysis of liposomes. The PlnEF and PlnJK displayed similar mechanisms by targeting and disrupting the bacterial cell membrane. Interestingly, Pln enhanced the effects of different antibiotics by 30- to 500-fold. CONCLUSION: This study shows that Pln in combination with low concentrations of antibiotics is efficient against S. epidermidis and may be developed as potential treatment of infections.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacteriocins/pharmacology , Staphylococcus epidermidis/drug effects , Amino Acid Sequence , Bacteriocins/chemistry , Cell Membrane/drug effects , Colony Count, Microbial , Drug Combinations , Drug Synergism , Liposomes , Microbial Sensitivity Tests , Microbial Viability/drug effects , Protein Precursors/pharmacology , Staphylococcal Infections/drug therapy , Staphylococcal Infections/microbiology , Staphylococcus epidermidis/cytology
SELECTION OF CITATIONS
SEARCH DETAIL